| Value | ₹0.01 Cr |
|---|
BSE filing, NSE: AXISCADES. Summary written from the filing by ALFA Finder's alert engine.
AXISCADES Technologies Ltd: key numbers
- Share price
- ₹2,014.60
- Market cap
- ₹8,569 Cr
- Revenue (annual)
- ₹1,159 Cr
- Net profit (annual)
- ₹71.92 Cr
- P/E (TTM)
- 235.8×Sector 52.2×
- Promoter holding
- 44.82%-13.21% QoQ
- FII holding
- 1.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AXISCADES Technologies Ltd
All →AXISCADES Technologies Employee Stock Options
AXISCADES Technologies granted 2,46,340 stock options to eligible employees under its ESOP 2018 Series 1 and 2 scheme. The exercise price is Rs.1,440 per share, with an 8-year exercise period.
AXISCADES Technologies Other Announcement
Axiscades Technologies Ltd has filed its quarterly shareholding pattern for the period ended 30 September 2026. This disclosure is a routine regulatory compliance requirement.
AXISCADES Technologies Merger & Restructuring Worth ₹0.01 Cr
AXISCADES Technologies incorporated a wholly-owned subsidiary, Xponential Space Private Limited, for space and aerospace technology, with an initial investment of Rs. 1 Lakh.
- Value
- ₹0.01 Cr
AXISCADES Technologies Management Change
AXISCADES Technologies appointed Mr. Uttam Kumar Bhageria as CFO-Designate, effective October 21, 2026. He will succeed retiring CFO Shashidhar SK starting January 1, 2027.
AXISCADES Technologies Acquisition Worth ₹66.5 Cr
Axiscades Technologies' subsidiary, XIDA Inc., will acquire substantially all business assets of US-based ITSJ Group for up to US$ 7.0 million (~₹66.5 Crore).
- Value
- ₹66.50 Cr
AXISCADES Technologies Share Pledge
Jupiter Capital Private Limited, a promoter of Axiscades Technologies, released a pledge on 27,000 shares valued at approximately Rs.6.18 Crore.
- Value
- ₹6.18 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.